This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling?
by Debanjana Dey
Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right now? Let's dive in.
HIMSPositive Net Change TEMPositive Net Change
medical medical-devices
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
by Zacks Equity Research
INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.
BSXNegative Net Change IDXXNegative Net Change STENegative Net Change INSPNegative Net Change
medical medical-devices
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
by Zacks Equity Research
ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.
CAHNegative Net Change COOPositive Net Change VCYTPositive Net Change ITGRNegative Net Change
medical medical-devices
BD and Ypsomed Expand Partnership to Target Growing Biologics Market
by Zacks Equity Research
BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.
BDXNegative Net Change CAHNegative Net Change COOPositive Net Change WSTNegative Net Change
medical medical-devices
Citizens Financial Services (CZFS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
CZFSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Medical Supply Stocks Poised to Gain in a Prospering Industry
by Indrajit Bandyopadhyay
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.
MCKNegative Net Change ALGNNegative Net Change CAHNegative Net Change WSTNegative Net Change
medical medical-devices
Hologic Q1 Earnings Preview: How Should You Play the Stock Now?
by Moumi Mondal
HOLX heads into Q1 earnings with rising EPS and revenue estimates, strong segment momentum and a pending buyout limiting near-term upside.
ABTNegative Net Change HOLXNegative Net Change QGENNegative Net Change
earnings-preview medical medical-devices
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
by Zacks Equity Research
BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
BDXNegative Net Change CAHNegative Net Change COOPositive Net Change VCYTPositive Net Change
medical medical-devices
CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February
by Zacks Equity Research
CAPR said the FDA wants the full HOPE-3 study report for Deramiocel and confirmed no new clinical trials are needed.
BSXNegative Net Change IDXXNegative Net Change STENegative Net Change CAPRNegative Net Change
medical medical-devices
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
by Urmimala Biswas
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
DOCSPositive Net Change OMCLPositive Net Change TXGPositive Net Change
artificial-intelligence earnings hospitals medical medical-devices
ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?
by Indrajit Bandyopadhyay
Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.
MDTPositive Net Change ISRGPositive Net Change
medical medical-devices
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
by Zacks Equity Research
Revvity's diagnostics strength and fast-growing Signals Software support long-term growth, even as macro pressures and weak funding linger.
BSXNegative Net Change IDXXNegative Net Change STENegative Net Change RVTYPositive Net Change
medical medical-devices
Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now?
by Zacks Equity Research
IDXX rides on strong CAG Diagnostics momentum and growing global software adoption, but currency pressure and solvency risks cloud the outlook.
BSXNegative Net Change IDXXNegative Net Change PAHCNegative Net Change NVSTNegative Net Change
medical medical-devices
Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings?
by Moumi Mondal
HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift upcoming Q1 results.
ABTNegative Net Change ISRGPositive Net Change HOLXNegative Net Change
medical medical-devices
Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?
by Zacks Equity Research
ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.
BSXNegative Net Change ISRGPositive Net Change TMOPositive Net Change
medical medical-devices
Organon Secures FDA Approval Extending NEXPLANON Use to Five Years
by Zacks Equity Research
OGN wins FDA approval to extend NEXPLANON use to five years, backed by trials showing no pregnancies and strong efficacy across body weights.
CRLNegative Net Change MDPositive Net Change ATRCPositive Net Change OGNPositive Net Change
medical medical-devices
Here's Why You Should Retain CLOV Stock in Your Portfolio for Now
by Zacks Equity Research
Clover Health shows strong membership growth, rising revenues and sustained EBITDA gains from Clover Assistant, though near-term margin pressure remains a risk.
CRLNegative Net Change MDPositive Net Change ATRCPositive Net Change CLOVPositive Net Change
medical medical-devices
New Strong Sell Stocks for January 20th
by Zacks Equity Research
DAR, CADL and DRTS have been added to the Zacks Rank #5 (Strong Sell) List on January 20, 2026.
DARPositive Net Change CADLNo Net Change DRTSPositive Net Change
consumer-staples medical medical-devices
Should You Still Hold GMED Stock in Your Portfolio?
by Zacks Equity Research
Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.
BSXNegative Net Change GMEDPositive Net Change PAHCNegative Net Change NVSTNegative Net Change
medical medical-devices
How Tilray Brands Is Acting on Its Vast International Opportunity
by Moumi Mondal
TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader global expansion.
TLRYPositive Net Change VFFNegative Net Change SNDLPositive Net Change
medical medical-devices
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
by Zacks Equity Research
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
ISRGPositive Net Change ATRCPositive Net Change EKTAYPositive Net Change VCYTPositive Net Change
medical medical-devices
SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal
by Zacks Equity Research
SNN expands its Sports Medicine portfolio with Integrity Orthopaedics, adding next-gen Tendon Seam tech to strengthen leadership in shoulder repair.
BSXNegative Net Change SNNPositive Net Change IDXXNegative Net Change STENegative Net Change
medical medical-devices
Here's Why You Should Hold DaVita Stock in Your Portfolio for Now
by Zacks Equity Research
DVA stock benefits from a patient-centric model, third-quarter revenue growth and overseas expansion, though reliance on commercial payers remains a risk.
BSXNegative Net Change DVAPositive Net Change IDXXNegative Net Change STENegative Net Change
medical medical-devices
Hims & Hers Expands Platform-Led Access to Digital Healthcare
by Debanjana Dey
HIMS leverages a software-driven platform to scale personalized digital care across new health categories and markets.
TDOCPositive Net Change AMWLPositive Net Change HIMSPositive Net Change
medical medical-devices
AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics?
by Indrajit Bandyopadhyay
Intuitive Surgical is positioning da Vinci 5 as a data-driven platform, using AI, software and surgical data to expand beyond robotics into insights.
BSXNegative Net Change ISRGPositive Net Change GEHCPositive Net Change
medical medical-devices